Argenx (ARGX) Blueprint Medicines (BPMC) and Sarepta Therapeutics (SRPT) are likely takeover targets in the biotech sector, according to a report by Wedbush.
https://seekingalpha.com/news/3973619-argenx-blueprint-medicines-sarepta-likely-ma-targets-analyst
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.